Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders — Stella

Home/Ovary; Anomaly/Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders

View on ClinicalTrials.gov

Recruiting

Back to Ovary; Anomaly trials

Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Greece

Genesis AC, Athens

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Genesis Athens Clinic

Collaborators

National and Kapodistrian University of Athens

Enrollment target

~100 participants

Started

May 2019

Primary completion

January 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

35 Years – 47 Years

Sex

Female only

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.